Volume 37, Issue 2
Special Issue Paper

Improved estimation of the cumulative incidence of rare outcomes

David Benkeser

Corresponding Author

E-mail address: benkeser@emory.edu

Department of Biostatistics and Bioinformatics, Emory University, Atlanta, U.S.A.

Correspondence to: David Benkeser, Department of Biostatistics and Bioinformatics Robert W. Woodruff Health Sciences Center Emory University 1518 Clifton Road, NE Mailstop: 1518‐002‐3AA Atlanta, Georgia 30322.

E‐mail: benkeser@emory.edu

Search for more papers by this author
Marco Carone

Department of Biostatistics, University of Washington, Seattle, U.S.A.

Search for more papers by this author
Peter B. Gilbert

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, U.S.A.

Search for more papers by this author
First published: 02 July 2017
Citations: 3

Abstract

Studying the incidence of rare events is both scientifically important and statistically challenging. When few events are observed, standard survival analysis estimators behave erratically, particularly if covariate adjustment is necessary. In these settings, it is possible to improve upon existing estimators by considering estimation in a bounded statistical model. This bounded model incorporates existing scientific knowledge about the incidence of an event in the population. Estimators that are guaranteed to agree with existing scientific knowledge on event incidence may exhibit superior behavior relative to estimators that ignore this knowledge. Focusing on the setting of competing risks, we propose estimators of cumulative incidence that are guaranteed to respect a bounded model and show that when few events are observed, the proposed estimators offer improvements over existing estimators in bias and variance. We illustrate the proposed estimators using data from a recent preventive HIV vaccine efficacy trial. Copyright © 2017 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 3

  • Targeted estimation of heterogeneous treatment effect in observational survival analysis, Journal of Biomedical Informatics, 10.1016/j.jbi.2020.103474, 107, (103474), (2020).
  • Improved confidence intervals for a difference of two cause‐specific cumulative incidence functions estimated in the presence of competing risks and random censoring, Biometrical Journal, 10.1002/bimj.201900060, 62, 6, (1394-1407), (2020).
  • Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes, Biometrics, 10.1111/biom.13377, 0, 0, (2020).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.